Glucose oxidase (GOx) has been recognized as a "star"
enzyme catalyst involved in
cancer treatment in the past few years. Herein, GOx is mineralized with
manganese-doped
calcium phosphate (MnCaP) to form spherical nanoparticles (GOx-MnCaP NPs) by an in situ biomimetic mineralization method, followed by the loading of
doxorubicin (DOX) to construct a biodegradable, biocompatible, and
tumor acidity-responsive nanotheranostics for magnetic resonance imaging (MRI) and cascade reaction-enhanced cooperative
cancer treatment. The GOx-driven oxidation reaction can effectively eliminate intratumoral
glucose for
starvation therapy, and the elevated H2O2 is then converted into highly toxic
hydroxyl radicals via a Mn2+-mediated Fenton-like reaction for chemodynamic
therapy (CDT). Moreover, the acidity amplification due to the
gluconic acid generation will in turn accelerate the degradation of the nanoplatform and promote the Mn2+-H2O2 reaction for enhanced CDT. Meanwhile, the released Mn2+
ions can be used for MRI to monitor the treatment process. After carrying the anticancer
drug, the DOX-loaded GOx-MnCaP can integrate
starvation therapy, Mn2+-mediated CDT, and DOX-induced
chemotherapy together, which showed greatly improved therapeutic efficacy than each monotherapy. Such an orchestrated cooperative
cancer therapy demonstrated high-efficiency
tumor suppression on 4T1
tumor-bearing mice with minimal side effects. Our findings suggested that the DOX-loaded GOx-MnCaP nanotheranostics with excellent biodegradability and biocompatibility hold clinical translation potential for
cancer management.